Marinke Westerterp
Papers
2
Total Citations
108
H-Index
2
About
Dr. Marinke Westerterp is a leading colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques and improving patient outcomes through intraoperative innovation. Her most impactful work centers on preventing anastomotic leakage—a devastating complication—by pioneering the use of indocyanine green (ICG) near-infrared fluorescence imaging to assess bowel perfusion in real time. As principal investigator of the landmark AVOID trial (2024), a multicentre, randomised, phase 3 study, she demonstrated that ICG-guided perfusion assessment significantly reduces leakage rates in minimally invasive colorectal surgery, a finding with 84 citations that is reshaping standard practice. Dr. Westerterp also investigates national variations in the adoption of minimally invasive surgery for colorectal cancer, revealing how implementation disparities influence short-term outcomes (2022, 24 citations). Her work bridges surgical technique, quality assurance, and evidence-based guidelines, making her a key voice in the global push for safer, more effective colorectal care. With a career dedicated to translating cutting-edge imaging into tangible surgical benefits, Dr. Westerterp’s contributions are helping define the future of precision surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2